Citation Impact
Citing Papers
Effect of Intraoperative High Inspired Oxygen Fraction on Surgical Site Infection, Postoperative Nausea and Vomiting, and Pulmonary Function
2013
Rescuing the bottom billion through control of neglected tropical diseases
2009 Standout
Complexities of Assessing the Disease Burden Attributable to Leishmaniasis
2008
The re-emergence of natural products for drug discovery in the genomics era
2015 Standout
Lesleishmaniosesvues au travers du réseau international des Instituts Pasteur
2013
Leishmaniasis
2018 Standout
Syndemics and the biosocial conception of health
2017 Standout
Limited Effectiveness of High-Dose Liposomal Amphotericin B (AmBisome) for Treatment of Visceral Leishmaniasis in an Ethiopian Population With High HIV Prevalence
2011
National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications
2012 Standout
Alkaloids: Future prospective to combat leishmaniasis
2008
Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?
2007 Standout
Transmission Dynamics of Visceral Leishmaniasis in the Indian Subcontinent – A Systematic Literature Review
2016
The prevention of propofol injection pain by tramadol or ondansetron
2002
The role of liposomes in clinical nanomedicine development. What now? Now what?
2019 Standout
Can available interventions end preventable deaths in mothers, newborn babies, and stillbirths, and at what cost?
2014 Standout
Post-kala-azar dermal leishmaniasis
2003
Methodology of Clinical Trials Aimed at Assessing Interventions for Cutaneous Leishmaniasis
2013
Species-Directed Therapy for Leishmaniasis in Returning Travellers: A Comprehensive Guide
2014
Efficacy and Tolerability of Miltefosine for Childhood Visceral Leishmaniasis in India
2004
Natural products: An evolving role in future drug discovery
2011 Standout
Consensus Guidelines for Managing Postoperative Nausea and Vomiting
2003 Standout
Paromomycin
2008
Cutaneous leishmaniasis
2007 Standout
Effectiveness and Feasibility of Active and Passive Case Detection in the Visceral Leishmaniasis Elimination Initiative in India, Bangladesh, and Nepal
2010
HIV and Visceral Leishmaniasis Coinfection in Bihar, India: An Underrecognized and Underdiagnosed Threat Against Elimination
2014
Challenges and new discoveries in the treatment of leishmaniasis
2004
Global Estimates of Syphilis in Pregnancy and Associated Adverse Outcomes: Analysis of Multinational Antenatal Surveillance Data
2013 Standout
Effective clearance of intracellular Leishmania majorin vivo requires Pten in macrophages
2008 StandoutNobel
Combination therapy for visceral leishmaniasis
2010
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Post kala-azar dermal leishmaniasis: a neglected aspect of kala-azar control programmes
1992
PKDL and Other Dermal Lesions in HIV Co-infected Patients with Leishmaniasis: Review of Clinical Presentation in Relation to Immune Responses
2014
A substantial and confusing variation exists in handling of baseline covariates in randomized controlled trials: a review of trials published in leading medical journals
2009
Incidence of Symptomatic and Asymptomatic Leishmania donovani Infections in High-Endemic Foci in India and Nepal: A Prospective Study
2011
The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm
2017 Standout
Pharmaceutical and medicinal significance of sulfur (SVI)-Containing motifs for drug discovery: A critical review
2018 Standout
Development and comparative evaluation of two antigen detection tests for Visceral Leishmaniasis
2015
Leishmaniasis as an opportunistic infection in HIV-infected patients: determinants of relapse and mortality in a collaborative study of 228 episodes in a Mediterreanean region
2005
Consensus Guidelines for the Management of Postoperative Nausea and Vomiting
2013 Standout
Phenolic compounds, antioxidant activity and in vitro inhibitory potential against key enzymes relevant for hyperglycemia and hypertension of commonly used medicinal plants, herbs and spices in Latin America
2010 Standout
The lost hope of elimination of Kala-azar (visceral leishmaniasis) by 2010 and cyclic occurrence of its outbreak in India, blame falls on vector control practices or co-infection with human immunodeficiency virus or therapeutic modalities?
2014
Combination Treatment for Visceral Leishmaniasis Patients Coinfected with Human Immunodeficiency Virus in India
2015
Leishmaniasis Worldwide and Global Estimates of Its Incidence
2012 Standout
Clinical aspects of visceral leishmaniasis in HIV infection
2012
Oral Miltefosine for Leishmaniasis in Immunocompromised Patients: Compassionate Use in 39 Patients with HIV Infection
2004
Diverse Engineered Heme Proteins Enable Stereodivergent Cyclopropanation of Unactivated Alkenes
2018 StandoutNobel
Leishmaniasis, an emerging infection in travelers
2010
The immunology of post-kala-azar dermal leishmaniasis (PKDL)
2016
Anesthetic management of aortocaval fistula repair associated with aortic valve replacement, severe aortic regurgitation, and bacterial endocarditis
2011
Neglected Tropical Diseases in Sub-Saharan Africa: Review of Their Prevalence, Distribution, and Disease Burden
2009 Standout
Clinical Pharmacology of Tramadol
2004 Standout
A Randomized, Double-Blinded Comparison of Ondansetron, Droperidol, and Placebo for Prevention of Postoperative Nausea and Vomiting After Supratentorial Craniotomy
2000
Plant products with hypocholesterolemic potentials
2003
Inhibition of human low-density lipoprotein oxidation in vitro by Maharishi Ayur-Veda herbal mixtures
1992
Aminoglycosides: An Overview
2016
Antileishmanial activities of dihydrochalcones from piper elongatum and synthetic related compounds. Structural requirements for activity
2003
Comparison between liposomal formulations of amphotericin B
2016
A Comparison of the Combination of Aprepitant and Dexamethasone Versus the Combination of Ondansetron and Dexamethasone for the Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Craniotomy
2010
Polymeric micelles in drug delivery: An insight of the techniques for their characterization and assessment in biorelevant conditions
2021 Standout
Single-Dose Liposomal Amphotericin B for Visceral Leishmaniasis in India
2010
Asymptomatic leishmaniasis in kala-azar endemic areas of Malda district, West Bengal, India
2017
Stillbirths: the way forward in high-income countries
2011
SWEETLEAD: an In Silico Database of Approved Drugs, Regulated Chemicals, and Herbal Isolates for Computer-Aided Drug Discovery
2013
Discovery and resupply of pharmacologically active plant-derived natural products: A review
2015 Standout
Asymptomatic infection of visceral leishmaniasis in hyperendemic areas of Vaishali district, Bihar, India: a challenge to kala-azar elimination programmes
2011
Natural products in drug discovery
2008 Standout
Asymptomatic Infection with Visceral Leishmaniasis in a Disease-Endemic Area in Bihar, India
2010
Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity‐score matched samples
2009 Standout
Biomarkers for intracellular pathogens: establishing tools as vaccine and therapeutic endpoints for visceral leishmaniasis
2013
Anesthetic management of a patient with aortocaval fistula
2009
Liposomal amphotericin B as a treatment for human leishmaniasis
2012
Leishmaniasis
1999 Standout
A PHASE II DOSE-RANGING STUDY OF SITAMAQUINE FOR THE TREATMENT OF VISCERAL LEISHMANIASIS IN INDIA
2005
MoleculeNet: a benchmark for molecular machine learning
2017 Standout
Local treatment of tendinopathies and myofascial painsyndromes with the 5‐HT3receptor antagonist tropisetron
2004
Alkyl-Lysophospholipid Resistance in Multidrug-Resistant Leishmania tropica and Chemosensitization by a Novel P-Glycoprotein-Like Transporter Modulator
2001
A review of recent research on mechanics of multifunctional composite materials and structures
2010 Standout
In vitro and in vivo inhibition of microsomal lipid peroxidation by MA-631
1994
Stillbirths: Where? When? Why? How to make the data count?
2011 Standout
Interventions for Old World cutaneous leishmaniasis
2008
Role of Human Macrophage Polarization in Inflammation during Infectious Diseases
2018 Standout
Rapid tests for the diagnosis of visceral leishmaniasis in patients with suspected disease
2014
Therapeutic Glucocorticoid-Induced TNF Receptor-Mediated Amplification of CD4+ T Cell Responses Enhances Antiparasitic Immunity
2010 StandoutNobel
Advances in leishmaniasis
2005 Standout
Characterization of multifunctional structural capacitors for embedded energy storage
2009
Developments in Diagnosis of Visceral Leishmaniasis in the Elimination Era
2015
Human Leishmaniasis: Clinical, Diagnostic, and Chemotherapeutic Developments in the Last 10 Years
1997
Systematic evaluation of natural phenolic antioxidants from 133 Indian medicinal plants
2006 Standout
Marine natural products
2018 Standout
Leads from Indian medicinal plants with hypoglycemic potentials
2006 Standout
Longitudinal Seroepidemiologic Study of Visceral Leishmaniasis in Hyperendemic Regions of Bihar, India
2009
Point-of-Care Diagnostics for Global Health
2008 Standout
Natural product and natural product derived drugs in clinical trials
2014 Standout
Oral drug therapy for multiple neglected tropical diseases: a systematic review.
2007
Biomedical Importance of Indoles
2013 Standout
Plant Secondary Metabolites as Anticancer Agents: Successes in Clinical Trials and Therapeutic Application
2018 Standout
The Relationship between Leishmaniasis and AIDS: the Second 10 Years
2008
The Traditional Medicine and Modern Medicine from Natural Products
2016 Standout
Guidelines for Perioperative Care in Elective Rectal/Pelvic Surgery: Enhanced Recovery After Surgery (ERAS®) Society Recommendations
2012 Standout
Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)
2016
Sodium Antimony Gluconate Induces Generation of Reactive Oxygen Species and Nitric Oxide via Phosphoinositide 3-Kinase and Mitogen-Activated Protein Kinase Activation inLeishmania donovani-Infected Macrophages
2006
Review on some plants of Indian traditional medicine with antioxidant activity
2000 Standout
Optimal Dosing of Miltefosine in Children and Adults with Visceral Leishmaniasis
2012
Drug Resistance in Leishmaniasis
2006 Standout
Protective Efficacy of Secondary Prophylaxis Against Visceral Leishmaniasis in Human Immunodeficiency Virus Coinfected Patients Over the Past 10 Years in Eastern India
2016
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
Miltefosine Susceptibility and Resistance in Leishmania: From the Laboratory to the Field
2016
Works of Prabhat Kumar Sinha being referenced
Usefulness of the direct agglutination test in the early detection of subclinical Leishmania donovani infection: a community-based study
2005
Ambisome plus miltefosine for Indian patients with kala-azar
2010
Ondansetron Pretreatment to Alleviate Pain on Propofol Injection
1999
Phase 4 Trial of Miltefosine for the Treatment of Indian Visceral Leishmaniasis
2007
The Ayurvedic medicines Haritaki, Amla and Bahira reduce cholesterol-induced atherosclerosis in rabbits
1988
The treatment of visceral leishmaniasis (kala-azar) in India: no obvious signs of long-term success
2012
Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial
2011
Five-Year Field Results and Long-Term Effectiveness of 20 mg/kg Liposomal Amphotericin B (Ambisome) for Visceral Leishmaniasis in Bihar, India
2014
Miltefosine in a case of visceral leishmaniasis with HIV co-infection; and rising incidence of this disease in India
2000
Effectiveness and Safety of Liposomal Amphotericin B for Visceral Leishmaniasis under Routine Program Conditions in Bihar, India
2010
Visceral leishmaniasis (kala-azar)—the Bihar (India) perspective
2005
Risk Factors for Visceral Leishmaniasis Relapse in Immunocompetent Patients following Treatment with 20 mg/kg Liposomal Amphotericin B (Ambisome) in Bihar, India
2014
Injectable Paromomycin for Visceral Leishmaniasis in India
2007
Treatment of post-kala-azar dermal leishmaniasis with sodium stibogluconate.
1987
Antileishmanial drugs cause up-regulation of interferon-gamma receptor 1, not only in the monocytes of visceral leishmaniasis cases but also in cultured THP1 cells
2003
Post Kala-Azar Dermal Leishmaniasis following Treatment with 20 mg/kg Liposomal Amphotericin B (Ambisome) for Primary Visceral Leishmaniasis in Bihar, India
2014
A community-based, comparative evaluation of direct agglutination and rK39 strip tests in the early detection of subclinicalLeishmania donovaniinfection
2008
Leishmania donovani vs immunity: T-cells sensitized from Leishmania of one donor may modulate their cytokines pattern on re-stimulation with Leishmania from different donor in visceral leishmaniasis
2008
Effect of Lung Ventilation With 50% Oxygen in Air or Nitrous Oxide Versus 100% Oxygen on Oxygenation Index After Cardiopulmonary Bypass
2006
Anesthetic implications of surgical repair of an aortocaval fistula
2003
Visceral leishmaniasis: elimination with existing interventions
2011
Efficacy of amphotericin B in multi-drug resistant kala-azar in children in first decade of life
1993
Efficacy of Ondansetron in Prophylaxis of Postoperative Nausea and Vomiting in Patients Following Infratentorial Surgery
1999
Visceral Leishmaniasis and HIV Co-infection in Bihar, India: Long-term Effectiveness and Treatment Outcomes with Liposomal Amphotericin B (AmBisome)
2014
Ondansetron Pretreatment to Alleviate Pain on Propofol Injection
1999
Post-Kala-Azar Dermal Leishmaniasis in a Patient Treated with Injectable Paromomycin for Visceral Leishmaniasis in India
2012
Inefficacy of ethambutol, ethambutol plus isoniazid, INH plus rifampicin, co-trimoxazole and metronidazole in the treatment of kala-azar.
1989
Active vibration control of composite sandwich beams with piezoelectric extension-bending and shear actuators
2002
Phase 4 Pharmacovigilance Trial of Paromomycin Injection for the Treatment of Visceral Leishmaniasis in India
2011